Gerresheimer AG (ETR:GXI) has been assigned a €73.00 ($83.91) target price by research analysts at Goldman Sachs Group, Inc. (The) in a report released on Friday. The firm presently has a “neutral” rating on the stock.
GXI has been the topic of a number of other research reports. Berenberg Bank set a €85.00 ($97.70) price target on Gerresheimer AG and gave the company a “buy” rating in a research note on Wednesday, May 24th. J P Morgan Chase & Co set a €99.80 ($114.71) price objective on Gerresheimer AG and gave the stock a “buy” rating in a research report on Wednesday, May 31st. Commerzbank Ag set a €73.00 ($83.91) price objective on Gerresheimer AG and gave the stock a “neutral” rating in a research report on Thursday, July 13th. Deutsche Bank AG set a €82.00 ($94.25) price objective on Gerresheimer AG and gave the stock a “buy” rating in a research report on Friday, July 7th. Finally, DZ Bank AG reiterated a “neutral” rating on shares of Gerresheimer AG in a research report on Friday, June 9th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and four have assigned a buy rating to the company’s stock. Gerresheimer AG has an average rating of “Hold” and an average target price of €80.06 ($92.02).
Gerresheimer AG (ETR:GXI) opened at 71.471 on Friday. Gerresheimer AG has a 12 month low of €64.00 and a 12 month high of €79.47. The company’s 50-day moving average is €74.42 and its 200-day moving average is €73.18. The company has a market cap of €2.24 billion and a price-to-earnings ratio of 19.028.
ILLEGAL ACTIVITY WARNING: “Gerresheimer AG (GXI) PT Set at €73.00 by Goldman Sachs Group, Inc. (The)” was originally published by Community Financial News and is the sole property of of Community Financial News. If you are accessing this story on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this story can be viewed at https://www.com-unik.info/2017/07/18/gerresheimer-ag-gxi-pt-set-at-73-00-by-goldman-sachs-group-inc-the.html.
About Gerresheimer AG
Gerresheimer AG is a Germany-based company that is active in the pharmaceuticals and health care industry. It operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings.
What are top analysts saying about Gerresheimer AG? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Gerresheimer AG and related companies.